FR531M - - Google Patents
Info
- Publication number
- FR531M FR531M FR837316A FR837316A FR531M FR 531 M FR531 M FR 531M FR 837316 A FR837316 A FR 837316A FR 837316 A FR837316 A FR 837316A FR 531 M FR531 M FR 531M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR837316A FR531M (en:Method) | 1958-07-10 | 1960-08-31 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB22148/58A GB851287A (en) | 1958-07-10 | 1958-07-10 | 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof |
| FR798293A FR1333707A (fr) | 1959-06-23 | 1959-06-23 | Procédé de fabrication du 5-chlorotoluène-2,4-disulfamide et de ses sels alcalins |
| FR837316A FR531M (en:Method) | 1958-07-10 | 1960-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR531M true FR531M (en:Method) | 1961-05-23 |
Family
ID=10174686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR837316A Active FR531M (en:Method) | 1958-07-10 | 1960-08-31 |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR531M (en:Method) |
| GB (1) | GB851287A (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB959229A (en) * | 1960-11-18 | 1964-05-27 | Kyowa Hakko Kogyo Company Ltd | Method for producing l-isoleucine by fermentation process |
| DE3068986D1 (en) * | 1980-01-28 | 1984-09-27 | Merck & Co Inc | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors |
| IE50901B1 (en) * | 1980-03-04 | 1986-08-06 | Merck & Co Inc | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
| MXPA03004463A (es) | 2000-11-21 | 2003-08-19 | Sankyo Co | Composiciones medicas. |
| ATE502635T1 (de) | 2002-08-19 | 2011-04-15 | Pfizer | Kombinationstherapie gegen hyperproliferative erkrankungen |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
| EP2986599A1 (en) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| EP3025711B1 (en) | 2013-07-23 | 2020-11-18 | Daiichi Sankyo Company, Limited | Medicine for preventing or treating hypertension |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| PL3911648T3 (pl) | 2019-01-18 | 2025-03-10 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania |
-
1958
- 1958-07-10 GB GB22148/58A patent/GB851287A/en not_active Expired
-
1960
- 1960-08-31 FR FR837316A patent/FR531M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB851287A (en) | 1960-10-12 |